Avadel Pharmaceuticals

$8.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+0.82%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AVDL and other stocks, options, and ETFs commission-free!

About AVDL

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its products include Bloxiverz, Vazculep, Nouress, and Akovaz.

CEO
Gregory J. Divis
Employees
32
Headquarters
Dublin, Dublin
Founded
2015
Market Cap
506.99M
Price-Earnings Ratio
64.48
Dividend Yield
—
Average Volume
185.96K
High Today
$8.72
Low Today
$8.46
Open Price
$8.60
Volume
158.56K
52 Week High
$13.49
52 Week Low
$4.83

AVDL Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

KINZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure